Siga Technologies (SIGA) Net Cash Flow Growth (1y) (2011 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) Net Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 93.66% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -323.06% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 248.11% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 195.58% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -517.34% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -88.52% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 3,465.10% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 270.63% |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -36.82% |
| Jun 30, 2025 | 154.69% |
| Mar 31, 2025 | 209.46% |
| Dec 31, 2024 | -28.98% |
| Sep 30, 2024 | -50.61% |
| Jun 30, 2024 | 6.46% |
| Mar 31, 2024 | -137.17% |
| Dec 31, 2023 | 821.16% |
| Sep 30, 2023 | -6.65% |
| Jun 30, 2023 | -1.91% |
| Mar 31, 2023 | -66.30% |
| Dec 31, 2022 | -206.20% |
| Sep 30, 2022 | 15.62% |
| Jun 30, 2022 | -381.62% |
| Mar 31, 2022 | 541.10% |
| Dec 31, 2021 | -73.69% |
| Sep 30, 2021 | -122.14% |
| Jun 30, 2021 | 66.92% |
| Mar 31, 2021 | 86.41% |
| Dec 31, 2020 | 357.38% |